
Cornell Tests Tomato Sentinel Plants as Living Nitrogen Sensors

Cornell University is testing genetically engineered tomato plants that change color when nitrogen is scarce, turning the plants into visible sentinels for nutrient stress. The field trial at Musgrave Research Farm is the second season of work on the Red Alert system developed through the Center for Research on Programmable Plant Systems.
When the sentinel plants experience nitrogen deficiency, their leaves and flowers produce betanin, the red purple pigment found in beets. Researchers hope the signal could help growers see nutrient shortages earlier and target fertilizer more precisely, but the technology remains experimental.
The tomatoes are not intended to enter the food supply. The concept is to place sentinel plants alongside a commercial crop so their color provides a biological warning about conditions in the surrounding field.
Cornell reported that the 2025 field plants clearly distinguished low nitrogen conditions from plots with adequate nitrogen. An attempt to use the tomatoes to predict corn yield was less successful because the two crops had different management requirements.
The 2026 trial gives the tomatoes their own plot beside nonengineered plants and compares three treatments, low nitrogen, a standard rate and a recovery treatment that starts low before receiving the standard amount.
Early observations were complicated by powdery mildew and hot weather. Even so, researchers saw green leaves emerge after nitrogen was added to mature stressed plants, especially in a new line under evaluation.
The team is measuring plant color with low flying drones and handheld spectrophotometers, while also analyzing soil and leaf samples. Those measurements are needed to determine whether local color differences reliably track nitrogen rather than other stresses.
Major practical questions remain, including how many sentinel plants a field would need, how growers should interpret the color signal and whether the approach can extend to maize, water stress or other nutrient deficiencies. Cornell's trial is evidence of progress in field testing, not proof that a commercial product is ready.






Comments